Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Ludwig Enterprises Hires Anne Blackstone, CRNA as CEO and Director

New CEO Announces Intentions for a Major Heath and Technology Enterprise.

SPARKS, NV / ACCESSWIRE / July 12, 2022 / Ludwig Enterprises Inc. (OTC PINK:LUDG) Ludwig proudly announced the hiring of accomplished CEO Anne Blackstone, CRNA. Previously in May, Ludwig formed mRNAforLife, Inc., and Ms. Anne Blackstone, CRNA, was named CEO and sole director. As previously stated, mRNAforLife is exploring acquisitions of business enterprises or technologies related to the health field.

About Anne Blackstone, CRNA:

The mRNAforLife mission is potentially reaching a significant milestone with a recent acquisition and discovery that could be a tremendous milestone in the healthcare industry. Anne Blackstone added, "I am excited to take on this new role as CEO to bring forward the company's new direction, and innovative products that we believe are timely and cutting edge in health care sciences and technology. mRNA was the building block on which several of the recent Covid 19 vaccines were created. I look forward to future announcements and interactions with our shareholders as we roll out the company's new path of innovations in healthcare.

This news comes in a series of recent announcements of successful new funding rounds and new directional changes within the company.

About Ludwig: Ludwig Enterprises, Inc. is an innovative technology and health-related company. Ludwig is endeavoring to return to and expand healthy living and other health technology products. The Board of Directors believes this course change returning to our core focus will be in Ludwig shareholders' best interest.

SAFE HARBOR

Forward-looking statements in this release are made pursuant to the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Ludwig Enterprises; Inc. is not a guarantee of future performance. This news release includes forward-looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Ludwig Enterprises, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.

CONTACT:

Ludwig Enterprises,
Anne Blackstone, CRNA, CEO
786-235-9026

or

HQ@ludwigent.com

SOURCE: Ludwig Enterprises, Inc.



View source version on accesswire.com:
https://www.accesswire.com/708281/Ludwig-Enterprises-Hires-Anne-Blackstone-CRNA-as-CEO-and-Director

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.